정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 296 | Withdrawn | Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial | ARDS | Drug: Dexamethasone injection Drug: Placebos |
Phase 2 | University of Colorado, Denver | OTHER | 0 | All | 18 Years | |
| 295 | Active, not recruiting | Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease | COVID-19 | Drug: leflunomide | Phase 3 | Ashford and St. Peter's Hospitals NHS Trust | OTHER | 178 | All | 18 Years | Ashford and St Peters Hospital NHS Foundation Trust, Chertsey, United Kingdom |
| 294 | Not yet recruiting | Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection | Cytokine Release Syndrome | Drug: Tazemetostat | Phase 2 | Ciprian Gheorghe | OTHER | 82 | All | 18 Years ~ 85 Years | |
| 293 | Not yet recruiting | TCB008 in Patients With COVID-19 | Covid19 | Drug: TCB008 | Phase 2 | TC Biopharm | INDUSTRY | 12 | All | 18 Years ~ 65 Years | |
| 292 | Completed | TD-0903 for ALI Associated With COVID-19 | Lung Inflammation Associated With COVID-19 | Drug: TD-0903 Drug: Placebo |
Phase 2 | Theravance Biopharma | INDUSTRY | 235 | All | 18 Years ~ 80 Years | Theravance Biopharma Investigational Site, Duarte, California, United States Theravance Biopharma Investigational Site, Denver, Colorado, United States Theravance Biopharma Investigational Site, Sebring, Florida, United States Theravance Biopharma Investigational Site, Boston, Massachusetts, United States Theravance Biopharma Investigational Site, Fall River, Massachusetts, United States Theravance Biopharma Investigational Site, Kalispell, Montana, United States Theravance Biopharma Investigational Site, Glens Falls, New York, United States Theravance Biopharma, Hyde Park, New York, United States Theravance Biopharma Investigational Site, Columbus, Ohio, United States Theravance Biopharma Investigational Site, Allentown, Pennsylvania, United States Theravance Biopharma Investigational Site, Bethlehem, Pennsylvania, United States Theravance Biopharma Investigational Site, Wenatchee, Washington, United States Theravance Biopharma Investigational Site, Bela Vista, Brazil Theravance Biopharma Investigational Site, Botucatu, Brazil Theravance Biopharma Investigational Site, Caxias Do Sul, Brazil Theravance Biopharma Investigational Site, Sao Jose Do Rio Preto, Brazil Theravance Biopharma Investigational Site, Helsinki, Finland Theravance Biopharma Investigational Site, Turku, Finland Theravance Biopharma Investigational Site, Chisinau, Moldova, Republic of Theravance Biopharma Investigational Site, Bucharest, Romania Theravance Biopharma Investigational Site, Brovary, Ukraine Theravance Biopharma Investigational Site, Kyiv, Ukraine Theravance Biopharma Investigational Site, Kyiv, Ukraine Theravance Biopharma Investigational Site, Manchester, United Kingdom |
| 291 | Recruiting | TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation | Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19) | Drug: Nezulcitinib (TD-0903) Dose A Drug: Nezulcitinib (TD-0903) Dose B |
Phase 1 | Theravance Biopharma | INDUSTRY | 14 | All | 18 Years ~ 65 Years | Theravance Biopharma Investigational Site, Cypress, California, United States |
| 290 | Recruiting | TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic | Major Depressive Disorder | Device: Transcranial Direct Current Stimulation Device: Placebo-simulation of transcranial direct current stimulation Drug: Fluoxetine Tablets |
Phase 3 | El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico | OTHER | 172 | All | 10 Years ~ 17 Years | Instituto Nacional de Neurologia y Neurocirugia, Mexico City, Ciudad De Mexico, Mexico |